FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of ...

The Pill prevents pregnancy -- and maybe ovarian cancer, too, a new study suggests.Women who’ve ever used the contra ...

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new ...

The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

The rise of counterfeit fentanyl-laced pharmaceuticals threatens public health. Innovative molecular analytical methods are ...

retriever generates disease-specific transcriptional drug response signatures by merging transcriptional signatures over time, concentration, and cell-type. These signatures can then be matched to ...

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new study.

Figuring out how your genes and environment increase your likelihood of developing asthma, heart disease, cancer, dementia ...

Your physical environment, social life and lifestyle have as much an influence on your biology − and hence, how you process ...

DNA profiling technologies are rapidly advancing, creating the potential to identify individuals involved in making, packing and transporting illegal capsules by analyzing the exterior of the illicit ...

In 2023, more than 84,000 people in the U.S. died from overdosing on opioids—everything from prescription painkillers to ...